Mar 9 |
EyePoint Pharmaceuticals, Inc. (NASDAQ:EYPT) Analysts Just Slashed This Year's Revenue Estimates By 22%
|
Mar 8 |
EyePoint Pharmaceuticals, Inc. (NASDAQ:EYPT) Q4 2023 Earnings Call Transcript
|
Mar 8 |
EyePoint Pharmaceuticals Full Year 2023 Earnings: Beats Expectations
|
Mar 8 |
Q4 2023 EyePoint Pharmaceuticals Inc Earnings Call
|
Mar 7 |
EyePoint Pharmaceuticals Inc (EYPT) Reports Growth Amidst Strategic Shifts in Q4 and Full-Year 2023
|
Mar 7 |
EyePoint Pharmaceuticals, Inc. (EYPT) Q4 2023 Earnings Conference Call Transcript
|
Mar 7 |
Compared to Estimates, EyePoint Pharmaceuticals (EYPT) Q4 Earnings: A Look at Key Metrics
|
Mar 7 |
EyePoint Pharmaceuticals GAAP EPS of -$0.33 beats by $0.16, revenue of $14M beats by $5.3M
|
Mar 7 |
EyePoint Pharmaceuticals Reports Fourth Quarter and Full-Year 2023 Financial Results and Highlights Recent Corporate Developments
|
Mar 7 |
Earnings Scheduled For March 7, 2024
|